Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer

INTRODUCTION: A progressive loss of circulating anti-human epidermal growth factor receptor-2/neu (HER2) CD4(+) T-helper type 1 (Th1) immune responses is observed in HER2(pos)-invasive breast cancer (IBC) patients relative to healthy controls. Pathologic complete response (pCR) following neoadjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales: Datta, Jashodeep, Berk, Erik, Xu, Shuwen, Fitzpatrick, Elizabeth, Rosemblit, Cinthia, Lowenfeld, Lea, Goodman, Noah, Lewis, David A, Zhang, Paul J, Fisher, Carla, Roses, Robert E, DeMichele, Angela, Czerniecki, Brian J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488128/
https://www.ncbi.nlm.nih.gov/pubmed/25997452
http://dx.doi.org/10.1186/s13058-015-0584-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488128/
https://www.ncbi.nlm.nih.gov/pubmed/25997452
http://dx.doi.org/10.1186/s13058-015-0584-1

Ejemplares similares